Acute Assessment of the Aria CV System in Patients With WHO Groups 2 and 3 Pulmonary Hypertension

NACompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

July 12, 2021

Primary Completion Date

December 30, 2021

Study Completion Date

January 6, 2022

Conditions
Pulmonary Hypertension
Interventions
DEVICE

Aria CV Acute PH System

The Aria CV Acute PH System is indicated for evaluation of hemodynamic responses (e.g. pulmonary arterial compliance, cardiac output, and effective arterial elastance) to an intravascular Balloon catheter temporarily placed in the pulmonary artery in symptomatic adult patients with WHO Group 2 or WHO Group 3 pulmonary hypertension and right ventricular dysfunction.

Trial Locations (1)

Unknown

Medical University of Vienna, Vienna

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Aria CV, Inc

INDUSTRY

NCT05001711 - Acute Assessment of the Aria CV System in Patients With WHO Groups 2 and 3 Pulmonary Hypertension | Biotech Hunter | Biotech Hunter